Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Forward PE Ratio : 0.00 (As of Apr. 27, 2024)

View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Forward PE Ratio?

Taro Pharmaceutical Industries's Forward PE Ratio for today is 0.00.

Taro Pharmaceutical Industries's PE Ratio without NRI for today is 34.81.

Taro Pharmaceutical Industries's PE Ratio for today is 34.75.

Taro Pharmaceutical Industries Forward PE Ratio Historical Data

The historical data trend for Taro Pharmaceutical Industries's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Forward PE Ratio Chart

Taro Pharmaceutical Industries Annual Data

Trend

2018-12

2019-12

2020-12

2021-11

2022-11

2023-11

Forward PE Ratio

7.70

11.15

17.45

13.61

8.50

33.22

Taro Pharmaceutical Industries Quarterly Data
	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2022-03
Forward PE Ratio	14.84	13.11	11.66	7.70	9.82	9.52	10.06	11.15	8.47	10.26	13.40	17.45	19.53	18.25	16.13	10.32

Competitive Comparison of Taro Pharmaceutical Industries's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taro Pharmaceutical Industries's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Forward PE Ratio falls into.

Taro Pharmaceutical Industries Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Taro Pharmaceutical Industries (NYSE:TARO) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Taro Pharmaceutical Industries Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

TAL:Germany

Address

14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761

Website

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Executives

Sun Pharma Global Inc	10 percent owner
Sun Pharmaceutical Industries Ltd	10 percent owner, other: Affiliated Party	17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd.	10 percent owner	KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc	10 percent owner	FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403